Femoral localization and higher ultrafiltration rate but not concentration of heparin used for canal locking of hemodialysis catheter are negative predictors for its malfunction

American Journal of Nephrology

Volumn 28, Issue 2, 2008, Pages 298-303

  Brzosko, Szymon ^a   Hryszko, Tomasz ^a   Malyszko, Jolanta ^a   Malyszko, Jacek Stanisław ^a   Mazerska, Maria ^a   Myśliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Catheter thrombosis malfunction; Hemodialysis; Heparin; Temporary vascular access

Indexed keywords

HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD FLOW; CATHETER OCCLUSION; CATHETER THROMBOSIS; CATHETERIZATION; CONTROLLED STUDY; DEMOGRAPHY; DIALYSIS CATHETER; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ULTRAFILTRATION; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; CATHETERIZATION; CATHETERS, INDWELLING; COHORT STUDIES; EQUIPMENT FAILURE; FEMALE; FEMORAL VEIN; HEPARIN; HUMANS; JUGULAR VEINS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS;

EID: 38349019053     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111143     Document Type: Article

References (19)

1. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Vennegoor M, Wanner C, Wee P, Vanholder R: EBPG on vascular access. Nephrol Dial Transplant 2007;22:ii88-ii117.
2. Hayashi R, Huang E, Nissenson AR: Vascular access for hemodialysis. Nat Clin Pract Nephrol 2006;2:504-513.
3. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002;61:305-316.
4. Oliver MJ: Acute dialysis catheters. Semin Dial 2001;14:432-435.
5. Agharazii M, Plamondon I, Lebel M, Douville P, Desmeules S: Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock. Nephrol Dial Transplant 2005;20:1238-1240.
6. III. NKF-K/DOQI clinical practice guidelines for vascular access: Update 2000. Am J Kidney Dis 2001;37:S137-S181.
7. Weijmer MC, ter Wee PM: Temporary vascular access for hemodialysis treatment. Current guidelines and future directions. Contrib Nephrol. Basel, Karger, 2002, vol 142, pp 38-45.
8. Weijmer MC, Debets-Ossenkopp YJ, van de Vondervoort FJ, ter Wee PM: Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002;17:2189-2195.
9. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, Cho WY, Kim HK: Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 2006;69:161-164.
10. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002;13:2133-2139.
11. Betjes MG, van Agteren M: Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Ne phrol Dial Transplant 2004;19:1546-1551.
12. Kimata N, Nitta K, Akiba T, Tominaga K, Suzuki K, Watanabe Y, Haga T, Kawashima A, Miwa N, Nishida E, Aoki T, Nihei H: Catheter dysfunction and thrombosis of double-lumen hemodialysis catheters placed in the femoral vein. Clin Nephrol 2002;58:215-219.
13. Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO: A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 2001;59:1935-1942.
14. Yevzlin AS, Sanchez RJ, Hiatt JG, Washington MH, Wakeen M, Hofmann RM, Becker Y: Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement. Semin Dial 2007;20:351-354.
15. Bick RL, Frenkel EP: Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy. Clin Appl Thromb Hemost 1999;5(suppl 1):S7-S15.
16. Hryszko T, Brzosko S, Mazerska M, Malyszko J, Mysliwiec M: Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. A prospective study. Nephron Clin Pract 2004;96:c43-c47.
17. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN: Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000;58:2543-2545.
18. Weyde W, Badowski R, Krajewska M, Penar J, Moron K, Klinger M: Femoral and iliac vein stenoses after prolonged femoral vein catheter insertion. Nephrol Dial Transplant 2004;19:1618-1621.
19. Mickley V: Central venous catheters: many questions, few answers. Nephrol Dial Transplant 2002;17:1368-1373.